Zusammenfassung
Die kabellosen Schrittmachersysteme, insbesondere das Micra™ TPS-System, bieten eine sichere und effektive Alternative zu der bisherigen konventionellen transvenösen Therapie in Patienten mit unmöglichem oder erschwertem Zugangsweg und scheinen auch in Kombination mit anderen implantierbaren Geräten (S-ICD, Neurostimulatoren) keine Einschränkung von Effektivität oder Sicherheit zu zeigen. Auch neue Entwicklungen im Hinblick auf eine kabellose Resynchronisationstherapie sind durchaus vielversprechend und könnten zukünftig den Patienten evtl. kabel- oder operationsbedingte Komplikationen ersparen. Limitierend für die vollständige Implementierung dieser neuen Technologien im klinischen Alltag sind fehlende Daten und Studien, aber auch die Verfügbarkeit und die Kosten. Dennoch ist basierend auf der aktuell begrenzten, aber vielversprechenden Datenlage mit weiteren positiven Langzeitbeobachtungen und steigenden Implantationszahlen zu rechnen.
Abstract
Leadless pacing systems, especially the Micra™ TPS system, deliver an effective and safe alternative to the previous conventional transvenous systems in patients with impossible transvenous access and seem to be compatible with other implantable devices (S-ICD, deep brain stimulators) with no limitations in efficacy or safety. Also, new outlooks on leadless resynchronization therapy seem promising and could prevent future patients from lead- or operation-associated complications. Current limits to the implementation in everyday clinical practice are mostly the unavailability of the devices or cost issues through lack of health insurance reimbursement. However, more promising data through further studies and rising implantation rates are expected based on the positive current clinical data.
Literatur
Raatikainen MJP, Arnar DO, Merkely B et al (2017) A decade of information on the use of cardiac implantable electronic devices and interventional electrophysiological procedures in the European Society of Cardiology Countries: 2017 report from the European Heart Rhythm Association. Europace 19(suppl_2):ii1–ii90. https://doi.org/10.1093/europace/eux258
Larsson B, Elmqvist H, Ryden L et al (2003) Lessons from the first patient with an implanted pacemaker: 1958–2001. Pacing Clin Electrophysiol 26(1 Pt 1):114–124. https://doi.org/10.1046/j.1460-9592.2003.00162.x
Markewitz A, Bundesfachgruppe Herzschrittmacher und Defibrillatoren (2021) Annual report 2019 of the German pacemaker and defibrillator registry-part 1: cardiac pacemakers: Working group on cardiac pacemakers and cardioverter-defibrillators at IQTIG-Institute for Quality Assurance and Transparency in Healthcare. Herzschrittmacherther Elektrophysiol. https://doi.org/10.1007/s00399-021-00796-x
Udo EO, Zuithoff NP, van Hemel NM et al (2012) Incidence and predictors of short- and long-term complications in pacemaker therapy: the FOLLOWPACE study. Heart Rhythm 9(5):728–735. https://doi.org/10.1016/j.hrthm.2011.12.014
Kirkfeldt RE, Johansen JB, Nohr EA et al (2014) Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark. Eur Heart J 35(18):1186–1194. https://doi.org/10.1093/eurheartj/eht511
Reynolds D, Duray GZ, Omar R et al (2016) A leadless intracardiac transcatheter pacing system. N Engl J Med 374(6):533–541. https://doi.org/10.1056/NEJMoa1511643
Sieniewicz BJ, Betts TR, James S et al (2020) Real-world experience of leadless left ventricular endocardial cardiac resynchronization therapy: a multicenter international registry of the WiSE-CRT pacing system. Heart Rhythm 17(8):1291–1297. https://doi.org/10.1016/j.hrthm.2020.03.002
Ng JB, Chua K, Teo WS (2019) Simultaneous leadless pacemaker and subcutaneous implantable cardioverter-defibrillator implantation – when vascular options have run out. J Arrhythm 35(1):136–138. https://doi.org/10.1002/joa3.12140
Mondesert B, Dubuc M, Khairy P et al (2015) Combination of a leadless pacemaker and subcutaneous defibrillator: first in-human report. HeartRhythm Case Rep 1(6):469–471. https://doi.org/10.1016/j.hrcr.2015.07.009
Spickler JW, Rasor NS, Kezdi P et al (1970) Totally self-contained intracardiac pacemaker. J Electrocardiol 3(3/4):325–331. https://doi.org/10.1016/s0022-0736(70)80059-0
Reddy VY, Knops RE, Sperzel J et al (2014) Permanent leadless cardiac pacing: results of the LEADLESS trial. Circulation 129(14):1466–1471. https://doi.org/10.1161/CIRCULATIONAHA.113.006987
Reddy VY, Exner DV, Cantillon DJ et al (2015) Percutaneous implantation of an entirely intracardiac leadless pacemaker. N Engl J Med 373(12):1125–1135. https://doi.org/10.1056/NEJMoa1507192
Lakkireddy D, Knops R, Atwater B et al (2017) A worldwide experience of the management of battery failures and chronic device retrieval of the Nanostim leadless pacemaker. Heart Rhythm 14(12):1756–1763. https://doi.org/10.1016/j.hrthm.2017.07.004
Steinwender C, Khelae SK, Garweg C et al (2020) Atrioventricular synchronous pacing using a leadless ventricular pacemaker: results from the MARVEL 2 study. JACC Clin Electrophysiol 6(1):94–106. https://doi.org/10.1016/j.jacep.2019.10.017
Boveda S, Lenarczyk R, Haugaa KH et al (2018) Use of leadless pacemakers in Europe: results of the European Heart Rhythm Association survey. Europace 20(3):555–559. https://doi.org/10.1093/europace/eux381
Glikson M, Nielsen JC, Kronborg MB et al (2021) 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J. https://doi.org/10.1093/eurheartj/ehab364
Steinwender C, Lercher P, Schukro C et al (2020) State of the art: leadless ventricular pacing: a national expert consensus of the Austrian Society of Cardiology. J Interv Card Electrophysiol 57(1):27–37. https://doi.org/10.1007/s10840-019-00680-2
Duray GZ, Ritter P, El-Chami M et al (2017) Long-term performance of a transcatheter pacing system: 12-month results from the Micra Transcatheter Pacing Study. Heart Rhythm 14(5):702–709. https://doi.org/10.1016/j.hrthm.2017.01.035
Vamos M, Erath JW, Benz AP et al (2017) Incidence of cardiac perforation with conventional and with leadless pacemaker systems: a systematic review and meta-analysis. J Cardiovasc Electrophysiol 28(3):336–346. https://doi.org/10.1111/jce.13140
Tjong FV, Reddy VY (2017) Permanent leadless cardiac pacemaker therapy: a comprehensive review. Circulation 135(15):1458–1470. https://doi.org/10.1161/CIRCULATIONAHA.116.025037
Roberts PR, Clementy N, Al Samadi F et al (2017) A leadless pacemaker in the real-world setting: The Micra Transcatheter Pacing System Post-Approval Registry. Heart Rhythm 14(9):1375–1379. https://doi.org/10.1016/j.hrthm.2017.05.017
Chinitz L, Ritter P, Khelae SK et al (2018) Accelerometer-based atrioventricular synchronous pacing with a ventricular leadless pacemaker: results from the Micra atrioventricular feasibility studies. Heart Rhythm 15(9):1363–1371. https://doi.org/10.1016/j.hrthm.2018.05.004
Brignole M, Auricchio A, Baron-Esquivias G et al (2013) 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J 34(29):2281–2329. https://doi.org/10.1093/eurheartj/eht150
Morina-Vazquez P, Moraleda-Salas MT, Manovel-Sanchez AJ et al (2020) Early improvement of left ventricular ejection fraction by cardiac resynchronization through His bundle pacing in patients with heart failure. Europace 22(1):125–132. https://doi.org/10.1093/europace/euz296
Leon AR, Abraham WT, Curtis AB et al (2005) Safety of transvenous cardiac resynchronization system implantation in patients with chronic heart failure: combined results of over 2,000 patients from a multicenter study program. J Am Coll Cardiol 46(12):2348–2356. https://doi.org/10.1016/j.jacc.2005.08.031
Reddy VY, Miller MA, Neuzil P et al (2017) Cardiac resynchronization therapy with wireless left ventricular endocardial pacing: the SELECT-LV study. J Am Coll Cardiol 69(17):2119–2129. https://doi.org/10.1016/j.jacc.2017.02.059
Okabe T, Hummel JD, Bank AJ et al (2021) Leadless left ventricular stimulation with WiSE-CRT system—initial experience and results from phase I of SOLVE-CRT study (nonrandomized, roll-in phase). Heart Rhythm. https://doi.org/10.1016/j.hrthm.2021.06.1195
Dreger H, Maethner K, Bondke H et al (2012) Pacing-induced cardiomyopathy in patients with right ventricular stimulation for > 15 years. Europace 14(2):238–242. https://doi.org/10.1093/europace/eur258
Leclercq C, Cazeau S, Lellouche D et al (2007) Upgrading from single chamber right ventricular to biventricular pacing in permanently paced patients with worsening heart failure: the RD-CHF study. Pacing Clin Electrophysiol 30(Suppl 1):23–30. https://doi.org/10.1111/j.1540-8159.2007.00598.x
Montemerlo E, Pozzi M, De Ceglia S et al (2019) First-in-man fully leadless transvenous CRT‑P with a transseptal implant of WISE-CRT((R)) system and Micra((R)) PM. Pacing Clin Electrophysiol 42(11):1489–1492. https://doi.org/10.1111/pace.13750
Funasako M, Neuzil P, Dujka L et al (2020) Successful implementation of a totally leadless biventricular pacing approach. HeartRhythm Case Rep 6(3):153–157. https://doi.org/10.1016/j.hrcr.2019.12.002
Carabelli A, Jabeur M, Jacon P et al (2021) European experience with a first totally leadless cardiac resynchronization therapy pacemaker system. Europace 23(5):740–747. https://doi.org/10.1093/europace/euaa342
Bongiorni MG, Zucchelli G, Coluccia G et al (2016) Leadless cardiac pacemaker implant in a patient with two deep brain stimulators: a peaceful cohabitation beyond prejudices. Int J Cardiol 223:136–138. https://doi.org/10.1016/j.ijcard.2016.08.161
Tjong FV, Brouwer TF, Smeding L et al (2016) Combined leadless pacemaker and subcutaneous implantable defibrillator therapy: feasibility, safety, and performance. Europace 18(11):1740–1747. https://doi.org/10.1093/europace/euv457
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
F. Doldi, B. Biller, F. Reinke und L. Eckardt geben an, dass kein Interessenkonflikt besteht.
Für diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.
Rights and permissions
About this article
Cite this article
Doldi, F., Biller, B., Reinke, F. et al. Neue Entwicklungen bei kabellosen Schrittmachersystemen. Herz 46, 513–519 (2021). https://doi.org/10.1007/s00059-021-05075-6
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00059-021-05075-6